Dr Reddy’s, Dixon Technology & more: Top stocks to watch today

 Morgan Stanley maintained an equal-weight rating on Dr Reddy’s Labs, citing missed Q4FY26 estimates and a slight delay in Semaglutide ramp-up. Kotak Institutional Equities recommended buying Dixon Technologies, driven by strong consumer electronics performance. Citigroup reiterated its buy on Max Financial, highlighting margin improvements and sustained growth. Macquarie rated Berger Paints underperform, despite a constructive outlook. Morgan Stanley maintained an equal-weight rating on Dr Reddy’s Labs, citing missed Q4FY26 estimates and a slight delay in Semaglutide ramp-up. Kotak Institutional Equities recommended buying Dixon Technologies, driven by strong consumer electronics performance. Citigroup reiterated its buy on Max Financial, highlighting margin improvements and sustained growth. Macquarie rated Berger Paints underperform, despite a constructive outlook.